GB1530975A - Halogenated derivatives of the 16alpha-methylpregnane series processes for preparing them and pharmaceutical compositions containing them - Google Patents

Halogenated derivatives of the 16alpha-methylpregnane series processes for preparing them and pharmaceutical compositions containing them

Info

Publication number
GB1530975A
GB1530975A GB8713/77A GB871377A GB1530975A GB 1530975 A GB1530975 A GB 1530975A GB 8713/77 A GB8713/77 A GB 8713/77A GB 871377 A GB871377 A GB 871377A GB 1530975 A GB1530975 A GB 1530975A
Authority
GB
United Kingdom
Prior art keywords
methylpregnane
16alpha
preparing
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8713/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1530975A publication Critical patent/GB1530975A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB8713/77A 1976-03-02 1977-03-02 Halogenated derivatives of the 16alpha-methylpregnane series processes for preparing them and pharmaceutical compositions containing them Expired GB1530975A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7605854A FR2342738A1 (fr) 1976-03-02 1976-03-02 Nouveaux derives halogenes de la serie du 16a-methyl pregnane

Publications (1)

Publication Number Publication Date
GB1530975A true GB1530975A (en) 1978-11-01

Family

ID=9169832

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8713/77A Expired GB1530975A (en) 1976-03-02 1977-03-02 Halogenated derivatives of the 16alpha-methylpregnane series processes for preparing them and pharmaceutical compositions containing them

Country Status (16)

Country Link
JP (1) JPS52106855A (xx)
AT (1) AT355237B (xx)
AU (1) AU509948B2 (xx)
BE (1) BE851944A (xx)
CA (1) CA1082170A (xx)
CH (1) CH619969A5 (xx)
DE (1) DE2709078C2 (xx)
DK (1) DK156401C (xx)
FR (1) FR2342738A1 (xx)
GB (1) GB1530975A (xx)
IE (1) IE44866B1 (xx)
LU (1) LU76867A1 (xx)
NL (1) NL7702166A (xx)
PT (1) PT66261B (xx)
SE (1) SE7702250L (xx)
ZA (1) ZA771078B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127827A (en) * 1982-10-05 1984-04-18 Roussel Uclaf Pregnane compounds

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928301A (en) * 1958-06-20 1963-06-12 Scherico Ltd 9, 11-dihalogeno steroids
US3049554A (en) * 1959-06-01 1962-08-14 Schering Corp 9, 11-dihalogeno-3, 20-diketopregnanes and processes for their manufacture

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127827A (en) * 1982-10-05 1984-04-18 Roussel Uclaf Pregnane compounds

Also Published As

Publication number Publication date
ATA136577A (de) 1979-07-15
FR2342738B1 (xx) 1979-10-12
AT355237B (de) 1980-02-25
AU509948B2 (en) 1980-06-05
NL7702166A (nl) 1977-09-06
PT66261B (fr) 1979-01-17
JPS52106855A (en) 1977-09-07
DK156401C (da) 1990-01-08
IE44866B1 (en) 1982-04-21
DE2709078C2 (de) 1986-09-11
AU2280877A (en) 1978-09-07
LU76867A1 (xx) 1977-09-26
DE2709078A1 (de) 1977-09-08
DK156401B (da) 1989-08-14
FR2342738A1 (fr) 1977-09-30
CA1082170A (fr) 1980-07-22
DK88277A (da) 1977-09-03
CH619969A5 (en) 1980-10-31
JPS6150960B2 (xx) 1986-11-06
SE7702250L (sv) 1977-09-03
IE44866L (en) 1977-09-02
ZA771078B (en) 1978-04-26
PT66261A (fr) 1977-04-01
BE851944A (fr) 1977-09-01

Similar Documents

Publication Publication Date Title
GB1429922A (en) Steroid acetals processes for their manufacture and preparations containing them
AU543237B2 (en) Anti-cancer quinazoline derivatives
AU1655776A (en) Quinazoline derivatives
AU470731B2 (en) Derivatives of 1, 3-disubstituted 2, 4 (ih, 3h) quinazolinediones
IE44473L (en) 6,9,21-trihalo pregnanes
AU506317B2 (en) Quinazoline derivatives
AU526270B2 (en) Acid addition salt of 2beta,16beta diperidino 5 alpha androstane derivatives
NZ180049A (en) Derivatives of azetidine-2-one; their use ofr the preparation 2 or 3-cephem-3-ols, or their derivatives at the 3-position
PH16946A (en) Heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acid and pharmaceutical compositions containing the same
SE8206619D0 (sv) Mellanprodukter for framstellning av pyrimido(6,1-a)-isokinolin-4-on-derivat
GB1530975A (en) Halogenated derivatives of the 16alpha-methylpregnane series processes for preparing them and pharmaceutical compositions containing them
IE831145L (en) Pyridine derivatives
GB1184044A (en) Nitrofuryl-Oxadiazole Derivatives
IE41612L (en) Triazolo-isoquinolines
AU521096B2 (en) Pyrido [2, 1-b] quinazoline derivatives
AU515330B2 (en) Alpha-acetylenic & alpha-vinyl derivatives of histidine
IE780546L (en) 1,2-methylene steroids
IE40847B1 (en) Pyridazine derivatives
AU509855B2 (en) Compositions of 1, 2, 4-rhiadiazine derivatives
IE38686B1 (en) 3-hydrazonomethyl rifamycin sv
AU509348B2 (en) Quinazoline derivatives
GB1355663A (en) 19-nortestosterone 17- -p-substituted phenoxy-acetates
AU2998377A (en) 4-amino-benzo(b)bicyclo(33)noners derivatives with anti-depressant properties
AU501748B2 (en) Substituted 2h-pyran-2, 6(3h) dione derivatives
GB1455396A (en) 4,-o-sulphonyl-erythromycin-9-o-oxime derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940302